Experts Say Outdoor Air Pollution Causes Cancer
Not long ago, scientists declared that diesel fumes were cancer-causing and linked to lung cancer. An international body has now gone a step further in classifying outdoor air pollution.
Imaging Cancer Outlook
One of the frustrating facts about cancer is that doctors can’t tell if it’s going to come back after treatment. This may be changing, though, for lung cancer. An imaging technology has been found to be able to predict who may need more treatment.
Does Marijuana Cause Lung Cancer?
Scientists have long been debating whether or not marijuana can be linked to lung cancer. A 40-year review suggests that cannibis (marijuana) does increase lung cancer risks, but the study is flawed, according to a leading cancer expert.
A Crystal Ball for Lung Cancer
Lung cancer can be detected early using CT scans. But when doctors find nodules on these CT scans, it can be hard for them to tell which ones will likely turn out to be cancerous.
Good Old X-Rays For Spotting Lung Cancer
Chest X-rays are cheaper than CT scans, but are not routinely used to screen people who are at risk for lung cancer.
Is Bigger Better in Lung Cancer?
Though obesity can increase the risk of developing many diseases, the link between obesity and cancer outcomes is still not clear.
Put Lung Cancer to the Screening Test
Early diagnosis of lung cancer is extremely important. If the cancer is diagnosed at an early stage, it can be treated more effectively and patients can enjoy a better quality of life.
Advancing Treatment of Advanced Lung Cancer
When cancer is described as “advanced,” that means it has started to spread. Today, progress in understanding the origins of cancer and the development of new medications have improved patients' odds of living with and beyond advanced cancers.
New Rx Stalls Advanced Lung Cancer
Lung cancer isn’t a single disease. Changes in genes produce different versions of lung cancer — the most common cancer in the US. Now there's a new medication designed to treat one specific type of lung cancer.
FDA Approves New Treatment for a Type of Late-Stage Lung Cancer
The US Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.